Literature DB >> 25858759

Effect of diet-induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl/6J mice.

Matthew S Yorek1,2, Alexander Obrosov3, Hanna Shevalye3, Amey Holmes1, Matthew M Harper1,2,4, Randy H Kardon1,2,4, Mark A Yorek1,2,3,5.   

Abstract

We determined the impact diet-induced obesity (DIO) and types 1 and 2 diabetes have on peripheral neuropathy with emphasis on corneal nerve structural changes in C57Bl/6J mice. Endpoints examined included nerve conduction velocity, response to thermal and mechanical stimuli and innervation of the skin and cornea. DIO mice and to a greater extent type 2 diabetic mice were insulin resistant. DIO and both types 1 and 2 diabetic mice developed motor and sensory nerve conduction deficits. In the cornea of DIO and type 2 diabetic mice there was a decrease in sub-epithelial corneal nerves, innervation of the corneal epithelium, and corneal sensitivity. Type 1 diabetic mice did not present with any significant changes in corneal nerve structure until after 20 weeks of hyperglycemia. DIO and type 2 diabetic mice developed corneal structural damage more rapidly than type 1 diabetic mice although hemoglobin A1 C values were significantly higher in type 1 diabetic mice. This suggests that DIO with or without hyperglycemia contributes to development and progression of peripheral neuropathy and nerve structural damage in the cornea.
© 2015 Peripheral Nerve Society.

Entities:  

Keywords:  corneal confocal microscopy; corneal nerves; diabetes; diabetic peripheral neuropathy; obesity

Mesh:

Substances:

Year:  2015        PMID: 25858759      PMCID: PMC4470853          DOI: 10.1111/jns.12111

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  36 in total

1.  Leptin restores the insulinotropic effect of exenatide in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and high-fat diet.

Authors:  Takeru Sakai; Toru Kusakabe; Ken Ebihara; Daisuke Aotani; Sachiko Yamamoto-Kataoka; Mingming Zhao; Valentino Milton Junior Gumbilai; Chihiro Ebihara; Megumi Aizawa-Abe; Yuji Yamamoto; Michio Noguchi; Junji Fujikura; Kiminori Hosoda; Nobuya Inagaki; Kazuwa Nakao
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

2.  Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.

Authors:  Vishal R Mali; Ruizhuo Ning; Jieli Chen; Xiao-Ping Yang; Jiang Xu; Suresh S Palaniyandi
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-20

Review 3.  Diabetic cardiac autonomic neuropathy: insights from animal models.

Authors:  Catherine L Stables; Rebecca L Glasser; Eva L Feldman
Journal:  Auton Neurosci       Date:  2013-04-03       Impact factor: 3.145

4.  The protection of Rhein lysinate to liver in diabetic mice induced by high-fat diet and streptozotocin.

Authors:  Ya-Jun Lin; Gang Hu; Kai-Ji Li; Yu-Fang Zhao; Jie Wei; Yong-Zhan Zhen
Journal:  Arch Pharm Res       Date:  2014-06-28       Impact factor: 4.946

5.  Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet-induced obesity and type 2 diabetic rats.

Authors:  Eric P Davidson; Lawrence J Coppey; Randy H Kardon; Mark A Yorek
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-03       Impact factor: 4.799

6.  Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin.

Authors:  Ningxia Zhu; Bin Liu; Wenhong Luo; Yingzhan Zhang; Hui Li; Shasha Li; Yingbi Zhou
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-30       Impact factor: 4.733

7.  Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin.

Authors:  Debbie K Chen; Katie E Frizzi; Lucie S Guernsey; Kelsey Ladt; Andrew P Mizisin; Nigel A Calcutt
Journal:  J Peripher Nerv Syst       Date:  2013-12       Impact factor: 3.494

8.  Baicalein Protects against Type 2 Diabetes via Promoting Islet β-Cell Function in Obese Diabetic Mice.

Authors:  Yu Fu; Jing Luo; Zhenquan Jia; Wei Zhen; Kequan Zhou; Elizabeth Gilbert; Dongmin Liu
Journal:  Int J Endocrinol       Date:  2014-07-23       Impact factor: 3.257

Review 9.  Update on the pathogenesis of diabetic neuropathy.

Authors:  Irina G Obrosova
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

10.  Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance.

Authors:  Omar Asghar; Ioannis N Petropoulos; Uazman Alam; Wendy Jones; Maria Jeziorska; Andrew Marshall; Georgios Ponirakis; Hassan Fadavi; Andrew J M Boulton; Mitra Tavakoli; Rayaz A Malik
Journal:  Diabetes Care       Date:  2014-06-26       Impact factor: 19.112

View more
  27 in total

1.  High fat diet induces pre-type 2 diabetes with regional changes in corneal sensory nerves and altered P2X7 expression and localization.

Authors:  Krisandra Kneer; Michael B Green; Jenna Meyer; Celeste B Rich; Martin S Minns; Vickery Trinkaus-Randall
Journal:  Exp Eye Res       Date:  2018-06-05       Impact factor: 3.467

2.  Sensory nerve regeneration after epithelium wounding in normal and diabetic cornea.

Authors:  Fu-Shin Yu; Jia Yin; Patrick Lee; Frank S Hwang; Mark McDermott
Journal:  Expert Rev Ophthalmol       Date:  2015-06-26

3.  Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes.

Authors:  Hanna Shevalye; Matthew S Yorek; Lawrence J Coppey; Amey Holmes; Matthew M Harper; Randy H Kardon; Mark A Yorek
Journal:  J Neurophysiol       Date:  2015-04-29       Impact factor: 2.714

Review 4.  Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.

Authors:  Gordon Sloan; Dinesh Selvarajah; Solomon Tesfaye
Journal:  Nat Rev Endocrinol       Date:  2021-05-28       Impact factor: 43.330

5.  Effect of tempol on peripheral neuropathy in diet-induced obese and high-fat fed/low-dose streptozotocin-treated C57Bl6/J mice.

Authors:  Alexander Obrosov; Hanna Shevalye; Lawrence J Coppey; Mark A Yorek
Journal:  Free Radic Res       Date:  2017-04-19

6.  Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.

Authors:  Matthew S Yorek; Alexander Obrosov; Hanna Shevalye; Lawrence J Coppey; Randy H Kardon; Mark A Yorek
Journal:  Neuropharmacology       Date:  2016-12-23       Impact factor: 5.250

Review 7.  The Potential Role of Fatty Acids in Treating Diabetic Neuropathy.

Authors:  Mark A Yorek
Journal:  Curr Diab Rep       Date:  2018-08-25       Impact factor: 4.810

Review 8.  Alternatives to the Streptozotocin-Diabetic Rodent.

Authors:  M A Yorek
Journal:  Int Rev Neurobiol       Date:  2016-03-28       Impact factor: 3.230

Review 9.  Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes.

Authors:  Adviye Ergul; Sherif Hafez; Abdelrahman Fouda; Susan C Fagan
Journal:  Transl Stroke Res       Date:  2016-03-30       Impact factor: 6.829

Review 10.  Impacts of high fat diet on ocular outcomes in rodent models of visual disease.

Authors:  Danielle A Clarkson-Townsend; Amber J Douglass; Anayesha Singh; Rachael S Allen; Ivie N Uwaifo; Machelle T Pardue
Journal:  Exp Eye Res       Date:  2021-01-11       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.